Publication: Correction to: Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Loading...
Identifiers
Date
2019-01-28
Authors
Driessen, M T
Whalen, J
Buguth, B Seewoodharry
Vallejo-Aparicio, L A
Naya, I P
Asukai, Y
Alcázar-Navarrete, B
Miravitlles, M
García-Río, F
Risebrough, N A
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Following publication of the original article [1], we have been notified of the below corrections to the 5th paragraph in the Discussion section.